DarkIris Inc. (NASDAQ: DKI) has 6.25 billion shares authorized — more than 6,600 times its current outstanding count of roughly 943,000. That gap is the structural headline, but the immediate risk sits closer to the surface.
The company's October 2026 F-1 offering included warrants that give holders a zero-exercise-price option — meaning the holder can convert each warrant into approximately 12.57 Class A shares without paying any cash. Up to 1,047,619 post-split shares were registered under that mechanism against a pre-offering base of just 41,952. Most have already been exercised. An estimated 229,681 remain outstanding and can be converted and sold at any time through approximately April 6, 2027.
That overhang equals roughly 25% of the current public float.
The float today
The tradeable float — shares available to the public market — stands at an estimated 927,075, or about 98% of shares outstanding. Insiders hold under 2%. Major data services still show a float near 285,000, a stale figure that appears to reflect a mid-exercise snapshot before the full wave of zero-price warrant conversions hit. The actual float is more than three times that reported number.
Float confidence is low. No closing 6-K — the foreign-issuer equivalent of an 8-K — has confirmed the final offering terms, the split between units and pre-funded warrants (an instrument priced at a nominal $0.005 that functions like a share), or the exact number of warrant exercises completed.
Reverse-split cycle
DKI executed two reverse splits in five months: a 1-for-16 on May 11, 2026, followed by a 1-for-50 on October 22, 2026. The cumulative ratio is 1-for-800. The second split came roughly two weeks after the zero-price-warrant offering. This is a textbook dilute-and-reset pattern: new shares flood the market, the nominal price compresses, and a reverse split restores it — until the next round.
Financing cadence
Three equity transactions landed in six months. In April 2026, a $3.79 million PIPE — a private investment in public equity — placed 9.4 million Class A shares and 1.43 million Class B shares (pre-split) at $0.35. Days later, 142,857 shares (post-1:16) were issued for $800,000 of short-drama intellectual property. Then came the October best-efforts offering — a deal structure with no minimum raise and no guarantee of full subscription — at a roughly 53% discount to the prior last sale, placed by Prime Number Capital.
Prime Number holds a six-month right of first refusal on follow-on deals, pointing to a possible next raise by approximately April 2027.
Key dates ahead
The company's 90-day lock-up expires around January 4, 2027, reopening the window for new issuance. The 180-day insider lock-up lifts around April 4, 2027, freeing 8,598 Class B shares — convertible one-for-one into Class A — held by CEO Hong Zhifang. The zero-price warrants expire around April 6, 2027.
ShareStructure assigns DKI a dilution risk score of 8 out of 10 (HIGH). The score reflects maximum warrant-overhang and recent-activity risk: outstanding share count grew approximately 3,650% since March 2026, and the remaining warrant shares require zero cash to exercise, which means they are perpetually in the money until expiration.